An observational study in Hepatitis C, Acute, Diabetes and Hypertension, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-18.
Sponsored by Cairo University · Observational
An observational double-blind cohort study that examined the association between HCV viral hepatitis, blood sugar level and systolic blood pressure in the Egyptian population
a cohort study on greater than 70000 Egyptian patients had been conducted. for all patients,1- we detected the Hepatitis C Virus (HCV) RNA antigens ( hepatitis C virus)presence using BIOLINE HCV kits( qualitative test for diagnosis of hepatitis C virus in the blood), For all positive patients, confirmatory rapid screening test was performed and all patients who tested positive twice underwent a qPCR test using QIAampMinElute Virus Spin kit (Thermo Fisher Scientific, Waltham, MA, USA) performed according to the manufacturer's recommended protocol.
2- Investigators measured blood sugar levels for each patient using ACCU-CHEK kits(finger stick sugar level measurement) 3- Measured systolic blood pressure for each patient was measured using mercury meters.
4-for all patients investigators obtained full medical history regarding the presence or absence of chronic diabetes, chronic hypertension, coronary artery disease, kidney impairment with dialysis or chronic obstructive pulmonary disease.
5- for all patients investigators listed age, gender, and body mass index. 66121 patients were negative for HCV and 4852 were positive for HCV. Investigators measured the association between HCV presence, high blood sugar levels and high systolic blood pressure.
It is supposed that this is the largest study in the world that examined both associations.
In a word, this study was responding to a specific question: is hepatitis c virus presence is associated with high blood pressure or high sugar level or both or not associated???
2,709 studies on the registry are indexed under Hepatitis A; 142 are open to participants now.
This study's enrollment of 71,975 is above the median of 250 across 687 observational studies indexed under Hepatitis A.
Browse Hepatitis A studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Egyptian patients aged 18-80 years.
Exclusion Criteria:
Patients tested positive for the hepatitis c virus antibodies by BIOLINE HCV kits.
Diagnostic Test: BIOLINE HCV kits · Diagnostic Test: ACCU-CHEK kits · Diagnostic Test: ErKameter 3000 mercury manometer
Patients tested negative for the hepatitis c virus antibodies by BIOLINE HCV kits.
Diagnostic Test: BIOLINE HCV kits · Diagnostic Test: ACCU-CHEK kits · Diagnostic Test: ErKameter 3000 mercury manometer
We used BIOLINE HCV kits to detect the presence of HCV antibodies in stick blood samples of all recruited patients.
Also known as: diagnosis of viral hepatitis C
For all patients, we measured random blood sugar levels by stick blood samples using ACCU-CHEK kits.
Also known as: measurement of blood sugar level
For all patients, we measured systolic blood pressure using ErKameter 3000 mercury manometer.
Also known as: blood pressure measurement
HCV diagnosis
Detection of patients who are HCV positive or negative
Time frame: 20 minutes
Measurement of blood sugar level in mg/dl
Detection of the percentage of patients with high blood sugar level in HCV positive or negative patients
Time frame: 1 minute
Measurement of systolic blood pressure in mmHg
Detection of the percentage of patients with high systolic blood pressure in HCV positive or negative patients
Time frame: 1 minute
Plan to share: No — No individual data will be shared with other researchers.
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University